ArticleViruses2026

Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead.

N G R Dayan Elshan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.